Skip to content
Disclosery

RLAY RELAY THERAPEUTICS INC

Follow

Stock (common), issuer CIK 1812364

202 managers (209 13F filers) reported a position in RLAY shares at 2025-06-30, 170,953,509 shares in all. 33 filers opened a position and 34 filers sold out during the quarter.

Managers
202
13F filers
209
New
33
Added
74
Reduced
55
Sold out
34
Shares held by filers
170,953,509

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Patel Sanjivdirector, officer (President and CEO)2026-10-07-48,199 S$18.1Form 4
Catinazzo Thomasofficer (Chief Financial Officer)2026-10-06-206 S$19.26Form 4
Catinazzo Thomasofficer (Chief Financial Officer)2026-10-06-17,511 S$18.58Form 4

13F holders, Q2 2025

Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Covestor Ltd24$00%-213F-HRTimelineValue filed as zero, left out of ratios.
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Patel Sanjiv sold 48,199 RLAY shares on 2026-10-07, Form 4 filed 2026-10-08. 0001193125-26-418096

    Accepted , ingested

  • Catinazzo Thomas sold 17,717 RLAY shares on 2026-10-06, Form 4 filed 2026-10-08. 0001193125-26-418094

    Accepted , ingested